To revascularize or not to revascularize: A dilemma in heart failure

CMAJ. Canadian Medical Association Journal

Volumn 175, Issue 4, 2006, Pages 372-373

  Senior, Roxy ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT;

CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG TOLERANCE; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MEDICAL DECISION MAKING; MEDICAL PRACTICE; META ANALYSIS; NOTE; PROGNOSIS; REVASCULARIZATION; SURVIVAL; SYSTEMATIC REVIEW; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; FORWARD HEART FAILURE; HEART MUSCLE REVASCULARIZATION; MORTALITY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; RISK FACTOR;

CARDIAC OUTPUT, LOW; CORONARY ARTERIOSCLEROSIS; HUMANS; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 33747484897     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.060882     Document Type: Note

References (16)

1. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. Increasing awareness and improving the management of heart failure in Europe: the Improvement of HF initiative. Eur J Heart Fail 1999; 1:139-44.
2. Melo LG, Pachori AS, Kong D, et al. Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism. Circulation 2004;109:2386-93.
3. Cleland JG, Pennell DJ, Ray SG, et al. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomized controlled trial. Lancet 2003;362:14-21.
4. Alderman E, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular dysfunction (CASS). Circulation 1983;68:785-95.
5. Bounous EP, Mark DB, Pollock BG, et al. Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation 1988;78:1151-7.
6. Krishnamani R, El-Zaru M, DeNofrio D. Contemporary medical, surgical, and device therapies for end-stage heart failure. Curr Treat Options Cardiovasc Med 2003;5:487-99.
7. Baker DW, Jones R, Hodges J, et al. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 1994;272:1528-34.
8. Holmes DR Jr, Detre KM, Williams DO, et al. Long-term outcome of patients with depressed left ventricular function undergoing percutaneous transluminal coronary angioplasty; the NHLBI PTCA registration. Circulation 1993;87:21-9.
9. Tsuyuki RT, Shrive FM, Galbraith PD, et al; for the APPROACH Investigators. Revascularization in patients with heart failure. CMAJ 2006;175(4):361-5.
10. Eitzman D, Al-Aouar ZR, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
11. Pagley PR, Beller GA, Watson DD, et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopamy and residual myocardial viability. Circulation 1997;96:793-800.
12. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularisation in patients with ischemic congestive heart failure. J Am Coll Cardiol 1999;33:1848-54.
13. Allman KC, Shaw LJ, Hachamovitch R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a metal-analysis. J Am Coll Cardiol 2002;39:1151-8.
14. Bourque JM, Hasselblad V, Velazquez EJ, et al. Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysis. Am Heart J 2003;146:621-7.
15. STICH investigators. Comparison of surgical and medical treatment for congestive heart failure and coronary artery disease [official study title: Surgical Treatment for Ischemic Heart Failure (STICH)]. Available: www.clinicaltrials.gov/ct/gui/show /NCT00023595 (accessed 2006 Jul 13).
16. Cleland JG, Freemantle N, Ball SG, et al. The Heart Failure Revascularisation Trial (HEART) rationale, design and methodology. Eur J Heurt Fail 2003;5:295-303.